ELISA Kit for Glycated Hemoglobin A1c (HbA1c)

Format

48T, 96T, 96T×5, 96T×10, 96T×100

Detection range

12.35-1,000ug/mL

Application

Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species

Homo sapiens (Human)

Sensitivity

The minimum detectable dose of this kit is typically less than 4.87ug/mL

Sample type

Serum, plasma and erythrocyte lysates

Assay length

2h

Method

Competitive Inhibition

Test principle

This assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Glycated Hemoglobin A1c (HbA1c) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled Glycated Hemoglobin A1c (HbA1c) and unlabeled Glycated Hemoglobin A1c (HbA1c) (Standards or samples) with the pre-coated antibody specific to Glycated Hemoglobin A1c (HbA1c). After incubation the unbound conjugate is washed off. Next, avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. The amount of bound HRP conjugate is reverse proportional to the concentration of Glycated Hemoglobin A1c (HbA1c) in the sample. After addition of the substrate solution, the intensity of color developed is reverse proportional to the concentration of Glycated Hemoglobin A1c (HbA1c) in the sample.

Alternative Names

Glycosylated Hemoglobin; Hemoglobin A1c; Hb1c; HbAIc; HbAIc

Item Name

Glycated Hemoglobin A1c

Research Area

Reference

The Effect of Vitamin D Supplementation on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes Mellitus;The Effect of Vitamin D Supplementation on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes Mellitus.;Circulating Betatrophin and Hepatocyte Growth Factor in Type 2 Diabetic Patients: Their Relationship With Disease Prognosis;d-Ribose as a Contributor to Glycated Haemoglobin;Plasma Cellular Hypoxia, Mitochondrial Dysfunction, Disease Risk and Prognostic Factors in Type 2 Diabetic Patients in Saudi Arabia.;1H Nuclear Magnetic Resonance (NMR)-Based Cerebrospinal Fluid and Plasma Metabolomic Analysis in Type 2 Diabetic Patients and Risk Prediction for Diabetic …;